Litcius/Paper detail

SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil

Camila Malta Romano, Alvina Clara Félix, Anderson Vicente de Paula, Jaqueline Góes de Jesus, Pâmela dos Santos Andrade, Darlan da Silva Cândido, Franciane Mendes de Oliveira, Andreia C. Ribeiro, Francini C. da Silva, Marta Inemami, Ângela Costa, Cibele O. D. Leal, Walter Manso Figueiredo, Claudio Sergio Pannuti, William Marciel de Souza, Nuno R. Faria, Éster Cerdeira Sabino

2021Revista do Instituto de Medicina Tropical de São Paulo41 citationsDOIOpen Access PDF

Abstract

Reinfection by the severe acute respiratory syndrome coronavirus type 2 (SARS-COV-2) has been reported in many countries, suggesting that the virus may continue to circulate among humans despite the possibility of local herd immunity due to massive previous infections. The emergence of variants of concern (VOC) that are more transmissible than the previous circulating ones has raised particular concerns on the vaccines effectiveness and reinfection rates. The P.1 lineage was first identified in December 2020 in Manaus city and is now globally spread. We report the first case of reinfection of SARS-CoV-2 caused by the P.1 variant outside of Manaus. The potential of these new variants to escape naturally and vaccine- induced immunity highlights the need for a global vigilance.

Topics & Concepts

Herd immunityLineage (genetic)ImmunityVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)CoronavirusImmunologyMedicineBiologyEnvironmental healthVaccinationImmune systemInfectious disease (medical specialty)DiseaseGeneticsInternal medicineGeneSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancyvaccines and immunoinformatics approaches
SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil | Litcius